Department of Pathological Physiology Laboratory of Immunogenomics Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic

Department of Pathological Physiology Laboratory of Immunogenomics Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic ; Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic

Zobrazit více v PubMed

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 183:788–824.10.1164/rccm.2009-040GL PubMed DOI PMC

Spagnolo P, Sverzellati N, Rossi G, Cavazza A, Tzouvelekis A, Crestani B, et al. Idiopathic pulmonary fibrosis: an update. Ann Med (2015) 47:15–27.10.3109/07853890.2014.982165 PubMed DOI

Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc (2006) 3:357–63.10.1513/pats.200601-010TK PubMed DOI

Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F, et al. TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci Signal (2014) 7:ra91.10.1126/scisignal.2005304 PubMed DOI

Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest (2009) 136:1364–70.10.1378/chest.09-0510 PubMed DOI PMC

Furuie H, Yamasaki H, Suga M, Ando M. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J (1997) 10:787–94. PubMed

Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Rachiotis G, et al. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 130:982–8.10.1378/chest.130.4.982 PubMed DOI

Barnes JC, Lumsden RV, Worrell J, Counihan IP, O’Beirne SL, Belperio JA, et al. CXCR3 is required for the IL-13 mediated upregulation of IL-13Ralpha2 in pulmonary fibroblasts. Am J Respir Cell Mol Biol (2014) 53:217–25.10.1165/rcmb.2013-0433OC PubMed DOI PMC

Luzina IG, Pickering EM, Kopach P, Kang PH, Lockatell V, Todd NW, et al. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol (2012) 189:403–10.10.4049/jimmunol.1200259 PubMed DOI PMC

Kishore A, Zissel G, Zizkova V, Mueller-Quernheim J, Petrek M. Association of mucin (MUC2, MUC5B) gene variants with idiopathic pulmonary fibrosis (IPF) in a German population: a pilot study using MassARRAY technology. Tissue Antigens (2015) 85:340.10.1111/tan.12557 DOI

Peljto AL, Selman M, Kim DS, Murphy E, Tucker L, Pardo A, et al. The MUC5B promoter polymorphism is associated with IPF in a Mexican cohort but is rare among Asian ancestries. Chest (2015) 147:460–4.10.1378/chest.14-0867 PubMed DOI PMC

Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA (2013) 309:2232–9.10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4382 PubMed DOI PMC

Petrek M, Kishore A, Zizkova V. Genetic association study for idiopathic pulmonary fibrosis in a Czech population: results from a pilot study using MassARRAY technology. Am J Respir Crit Care Med (2015) 191:A4382.10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4382 DOI

O’Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, et al. The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2013) 188:1442–50.10.1164/rccm.201304-0760OC PubMed DOI

O’Dwyer DN, Armstrong ME, Kooblall M, Donnelly SC. Targeting defective toll-like receptor-3 function and idiopathic pulmonary fibrosis. Expert Opin Ther Targets (2015) 19:507–14.10.1517/14728222.2014.988706 PubMed DOI

Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 24:37–55.10.1007/s10654-008-9302-y PubMed DOI PMC

Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet (2006) 7:781–91.10.1038/nrg1916 PubMed DOI

Ahn MH, Park BL, Lee SH, Park SW, Park JS, Kim DJ, et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir Res (2011) 12:73.10.1186/1465-9921-12-73 PubMed DOI PMC

Vasakova M, Sterclova M, Matej R, Olejar T, Kolesar L, Skibova J, et al. IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis. Hum Immunol (2013) 74:1346–51.10.1016/j.humimm.2013.07.011 PubMed DOI

Kropski JA, Lawson WE, Young LR, Blackwell TS. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech (2013) 6:9–17.10.1242/dmm.010736 PubMed DOI PMC

Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med (2013) 1:309–17.10.1016/S2213-2600(13)70045-6 PubMed DOI PMC

Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS One (2013) 8:e70621.10.1371/journal.pone.0070621 PubMed DOI PMC

Wang C, Zhuang Y, Guo W, Cao L, Zhang H, Xu L, et al. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. PLoS One (2014) 9:e104919.10.1371/journal.pone.0104919 PubMed DOI PMC

Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, et al. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology (2015) 20:439–44.10.1111/resp.12466 PubMed DOI

Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 165:148–51.10.1164/ajrccm.165.2.2106004 PubMed DOI

Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 45:613–20.10.1038/ng.2609 PubMed DOI PMC

Ding M, Sheng H, Shen W, Zhen J, Xi L, Zeng J, et al. Association of the SNP rs1800925(C/T) in the interleukin-13 gene promoter with pulmonary function in Chinese Han patients with idiopathic pulmonary fibrosis. Cell Biochem Biophys (2013) 67:905–9.10.1007/s12013-013-9580-1 PubMed DOI

Korthagen NM, van Moorsel CH, Barlo NP, Kazemier KM, Ruven HJ, Grutters JC. Association between variations in cell cycle genes and idiopathic pulmonary fibrosis. PLoS One (2012) 7:e30442.10.1371/journal.pone.0030442 PubMed DOI PMC

Uh ST, Kim TH, Shim EY, Jang AS, Park SW, Park JS, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis. Lung (2013) 191:345–51.10.1007/s00408-013-9469-1 PubMed DOI

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 16:1215.10.1093/nar/16.3.1215 PubMed DOI PMC

Bradic M, Costa J, Chelo IM. Genotyping with Sequenom. Methods Mol Biol (2011) 772:193–210.10.1007/978-1-61779-228-1_11 PubMed DOI

Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J, et al. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet (2006) 33:261–7.10.1111/j.1744-313X.2006.00609.x PubMed DOI

Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 364:1503–12.10.1056/NEJMoa1013660 PubMed DOI PMC

Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax (2013) 68:436–41.10.1136/thoraxjnl-2012-201786 PubMed DOI

Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, et al. Muc5b is required for airway defence. Nature (2014) 505:412–6.10.1038/nature12807 PubMed DOI PMC

Fletcher AA, Evans CM. Regulation of microbial populations and immune functions by Muc5b. Ann Am Thorac Soc (2014) 11:S80–S.10.1513/AnnalsATS.201308-263MG DOI

Sterclova M, Vasakova M, Metlicka M, Pavlicek J, Kolesar L, Striz I. Angiostatic versus angiogenic chemokines in IPF and EAA. Respir Med (2009) 103:1651–6.10.1016/j.rmed.2009.05.012 PubMed DOI

Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 185:67–76.10.1164/rccm.201101-0058OC PubMed DOI PMC

Murray LA, Zhang H, Oak SR, Coelho AL, Herath A, Flaherty KR, et al. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol (2014) 50:985–94.10.1165/rcmb.2013-0342OC PubMed DOI PMC

Hogaboam CM, Trujillo G, Martinez FJ. Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 5:S3.10.1186/1755-1536-5-S1-S3 PubMed DOI PMC

Trujillo G, Meneghin A, Flaherty KR, Sholl LM, Myers JL, Kazerooni EA, et al. TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med (2010) 2:57ra82.10.1126/scitranslmed.3001510 PubMed DOI PMC

Sanchez-Mazas A, Vidan-Jeras B, Nunes JM, Fischer G, Little AM, Bekmane U, et al. Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. Int J Immunogenet (2012) 39:459–72.10.1111/j.1744-313X.2012.01113.x PubMed DOI PMC

Lundmark PE, Liljedahl U, Boomsma DI, Mannila H, Martin NG, Palotie A, et al. Evaluation of HapMap data in six populations of European descent. Eur J Hum Genet (2008) 16:1142–50.10.1038/ejhg.2008.77 PubMed DOI

Heath SC, Gut IG, Brennan P, McKay JD, Bencko V, Fabianova E, et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 16:1413–29.10.1038/ejhg.2008.210 PubMed DOI

Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment

Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis

Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations